Methods for treating disorders or diseases associated with hyperlipidemia and hypercholesterolemia while minimizing side-effects

Details for Australian Patent Application No. 2005221656 (hide)

Owner The Trustees of the University of Pennsylvania

Inventors Rader, Daniel J.

Agent Pizzeys

Pub. Number AU-B-2005221656

PCT Pub. Number WO2005/087234

Priority 60/550,915 05.03.04 US

Filing date 7 March 2005

Wipo publication date 22 September 2005

Acceptance publication date 23 June 2011

International Classifications

A61K 31/405 (2006.01)

A61K 31/21 (2006.01) - Esters, e.g. nitroglycerine, selenocyanates

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

Event Publications

28 September 2006 PCT application entered the National Phase

  PCT publication WO2005/087234 Priority application(s): WO2005/087234

23 June 2011 Application Accepted

  Published as AU-B-2005221656

20 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005221659-Bioavailable solid dosage forms of metaxalone

2005221653-Method and apparatus for optical detection of mixed venous and arterial blood pulsation in tissue